StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
447
This month
4
This year
20
Publishing Date
2023 - 02 - 02
3
2023 - 01 - 27
3
2022 - 08 - 10
3
2022 - 06 - 06
3
2022 - 06 - 03
3
2022 - 06 - 02
3
2022 - 04 - 12
4
2022 - 04 - 05
3
2022 - 02 - 25
3
2021 - 11 - 12
3
2021 - 11 - 03
3
2021 - 10 - 01
3
2021 - 09 - 17
3
2021 - 09 - 16
3
2021 - 09 - 08
3
2021 - 08 - 19
3
2021 - 07 - 30
3
2021 - 07 - 27
2
2021 - 07 - 23
2
2021 - 07 - 16
2
2021 - 07 - 12
2
2021 - 07 - 09
3
2021 - 07 - 08
2
2021 - 07 - 01
2
2021 - 06 - 29
2
2021 - 06 - 25
3
2021 - 06 - 24
2
2021 - 06 - 17
3
2021 - 06 - 11
2
2021 - 06 - 10
5
2021 - 06 - 09
2
2021 - 06 - 04
3
2021 - 06 - 02
2
2021 - 05 - 25
2
2021 - 05 - 24
3
2021 - 05 - 21
2
2021 - 05 - 20
5
2021 - 05 - 19
3
2021 - 05 - 18
4
2021 - 05 - 13
2
2021 - 05 - 12
3
2021 - 05 - 05
2
2021 - 04 - 29
3
2021 - 04 - 28
4
2021 - 04 - 23
5
2021 - 04 - 22
2
2021 - 04 - 16
4
2021 - 04 - 14
3
2021 - 04 - 13
3
2021 - 04 - 12
2
2021 - 04 - 07
3
2021 - 03 - 25
2
2021 - 03 - 19
3
2021 - 03 - 11
2
2021 - 03 - 04
2
2021 - 01 - 20
2
2021 - 01 - 11
2
2021 - 01 - 04
2
2020 - 12 - 11
3
2020 - 12 - 08
2
Sector
Commercial services
1
Communications
1
Consumer non-durables
1
Distribution services
1
Electronic technology
2
Energy minerals
3
Finance
4
Finance and insurance
1
Health services
5
Health technology
447
Information
1
Manufacturing
42
N/a
6
Process industries
7
Producer manufacturing
1
Professional, scientific, and technical services
3
Retail trade
3
Technology services
2
Tags
Active
5
Alliances
12
Antibody
11
Antiviral
6
Application
16
Approval
40
Biotech
7
Biotech-bay
9
Biotechnology
5
Cancer
79
Car-t
7
Cardio
7
Cel
7
Chmp
14
Clinical-trials-phase-ii
14
Clinical-trials-phase-iii
10
Collaboration
23
Conference
13
Covid-19
5
Disease
18
Drug
51
Earnings
17
Europe
15
Ev
6
Events
18
Expected
7
Fda
9
Financial results
17
Food
19
For
36
Global
22
Growing
11
Growth
22
Immunotherapy
14
Int230
9
Iot
11
License
9
Market
58
N/a
218
Opdivo
17
People
11
Pharm-country
39
Pharmaceutical
9
Phase 1
9
Phase 2
9
Phase 3
12
Positive
22
Product-news
14
Psoriasis
6
Regulatory
6
Renal
8
Report
31
Research
47
Results
47
Solid tumors
10
T-cell
8
Therapeutics
27
Therapy
53
Treatment
62
Trial
32
Entities
3m company
641
Abb ltd
888
Abbott laboratories
1031
Abbvie inc.
645
Accenture plc
356
Alphabet inc.
542
Amgen inc.
481
Apple inc.
700
Arcelormittal
347
Arrival
2446
Astrazeneca plc
414
Becton, dickinson and company
562
Bnp paribas
993
Boston scientific corporation
402
Bristol-myers squibb company
447
Cisco systems, inc.
604
Danaher corporation
490
Dow inc.
373
Eli lilly and company
1131
Ericsson
1032
Express, inc.
436
Extreme networks, inc.
482
First bank
399
Firstenergy corp.
348
Ford motor company
384
Gartner, inc.
335
General electric company
652
Gilead sciences, inc.
353
Glaxosmithkline plc
604
Honeywell international inc.
1095
Hubspot, inc.
1010
Intel corporation
633
International business machines corporation
425
Johnson & johnson
2906
Kering
602
Koninklijke philips n.v.
620
Lithium corp
533
Live nation entertainment, inc.
471
Lockheed martin corporation
376
Medtronic plc
881
Microsoft corporation
853
Morgan stanley
2614
Nokia corp
469
Nokia corporation
485
Northrop grumman corporation
386
Novartis ag
736
Novo nordisk a/s
402
Ooma, inc.
393
Oracle corporation
786
Orange
3506
Panasonic corp
402
Pfizer, inc.
507
Sanofi
2675
Sap se
940
Snowflake inc.
527
Teva pharmaceutical industries ltd
364
Thermo fisher scientific inc
941
Total se
998
Verizon communications inc.
641
X financial
370
Symbols
ABBV
54
ABEO
4
ABT
20
ADCT
13
AGEN
5
AGIO
12
ALB
5
ALNY
10
ALPMF
4
ALPMY
4
ALXN
15
AMGN
62
AVEO
18
AYLA
4
AZN
36
AZNCF
28
BCRX
13
BGNE
10
BHC
5
BHVN
4
BIIB
4
BLUE
5
BMRN
5
BMY
447
BOLT
6
BPMC
19
CGEN
4
CLVS
20
EPZM
18
EXEL
26
GILD
35
GLAXF
33
GSK
50
ILMN
10
INCY
20
INTS
12
JNJ
55
KPTI
18
LLY
79
MDT
6
MYL
11
NEOS
13
NKTR
7
NVS
65
NVSEF
44
OMER
13
OTIC
13
PFE
52
REGN
28
REPL
6
RIGL
11
SNY
89
SNYNF
40
TAK
30
TEVJF
19
TPTX
6
VSTM
11
VTRS
10
XERS
10
YMAB
18
Exchanges
Amex
2
Lse
22
Nasdaq
263
Nyse
447
Tsx
4
Crawled Date
2023 - 02 - 02
3
2023 - 01 - 27
3
2022 - 08 - 10
3
2022 - 06 - 06
3
2022 - 06 - 03
3
2022 - 06 - 02
3
2022 - 04 - 12
4
2022 - 04 - 05
3
2022 - 02 - 25
3
2021 - 11 - 12
3
2021 - 11 - 03
3
2021 - 10 - 01
3
2021 - 09 - 17
3
2021 - 09 - 16
3
2021 - 09 - 08
3
2021 - 08 - 19
3
2021 - 08 - 03
2
2021 - 07 - 30
3
2021 - 07 - 27
3
2021 - 07 - 16
2
2021 - 07 - 09
3
2021 - 07 - 08
2
2021 - 07 - 01
2
2021 - 06 - 29
2
2021 - 06 - 25
3
2021 - 06 - 24
2
2021 - 06 - 18
2
2021 - 06 - 17
2
2021 - 06 - 11
2
2021 - 06 - 10
5
2021 - 06 - 09
2
2021 - 06 - 04
3
2021 - 06 - 02
2
2021 - 05 - 25
4
2021 - 05 - 21
2
2021 - 05 - 20
5
2021 - 05 - 19
3
2021 - 05 - 18
4
2021 - 05 - 13
2
2021 - 05 - 12
3
2021 - 05 - 05
2
2021 - 04 - 29
3
2021 - 04 - 28
4
2021 - 04 - 23
5
2021 - 04 - 22
2
2021 - 04 - 16
4
2021 - 04 - 15
2
2021 - 04 - 14
2
2021 - 04 - 13
4
2021 - 04 - 07
3
2021 - 03 - 29
2
2021 - 03 - 25
2
2021 - 03 - 19
3
2021 - 03 - 11
2
2021 - 03 - 04
2
2021 - 01 - 20
2
2021 - 01 - 11
2
2021 - 01 - 04
2
2020 - 12 - 11
3
2020 - 12 - 08
2
Crawled Time
00:00
10
00:01
1
01:00
4
02:00
2
03:00
2
04:00
1
05:00
1
06:00
1
07:00
2
08:00
3
08:20
1
09:00
2
10:00
5
10:41
1
10:43
1
10:51
2
10:57
1
11:00
16
11:36
1
12:00
84
12:02
1
12:04
1
12:15
15
12:20
10
12:24
1
12:30
8
12:34
1
13:00
46
13:07
1
13:13
1
13:15
4
13:17
1
13:20
8
13:27
1
13:30
3
13:50
1
14:00
22
14:03
1
14:15
1
14:20
7
14:30
5
14:58
1
15:00
23
15:01
1
15:15
2
15:20
3
15:49
1
16:00
22
16:01
1
16:20
1
17:00
18
18:00
12
18:04
2
18:26
2
18:31
2
19:00
11
20:00
12
21:00
20
22:00
11
23:00
6
Source
feed.businesswire.com
2
savarapharma.com
1
www.biospace.com
228
www.fda.gov
45
www.globenewswire.com
29
www.prnewswire.com
142
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Bristol-myers squibb company
save search
Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference
Published:
2023-02-03
(Crawled : 14:20)
- biospace.com/
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
0.65%
|
O:
0.65%
H:
0.0%
C:
0.0%
conference
The Global Antipsychotic Drugs Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsight
Published:
2023-02-02
(Crawled : 16:00)
- prnewswire.com
ATAI
|
$1.85
-5.61%
-5.95%
1.5M
|
Manufacturing
|
6.52%
|
O:
1.63%
H:
6.95%
C:
4.81%
VTRS
|
$12.17
-0.16%
-0.16%
7.1M
|
Health Technology
|
-0.57%
|
O:
-0.16%
H:
0.08%
C:
-0.41%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.03%
|
O:
-2.99%
H:
3.64%
C:
3.48%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
-0.16%
|
O:
-0.46%
H:
0.0%
C:
-0.75%
ACER
|
$2.235
3.0%
2.91%
210K
|
Health Technology
|
-4.82%
|
O:
-0.88%
H:
2.65%
C:
-3.98%
global
growth
market
The Global Antiviral Drugs Market to Exhibit Growth at a Paltry CAGR of ~4% by 2027 | DelveInsight
Published:
2023-02-02
(Crawled : 16:00)
- prnewswire.com
VTRS
|
$12.17
-0.16%
-0.16%
7.1M
|
Health Technology
|
-0.57%
|
O:
-0.16%
H:
0.08%
C:
-0.41%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-2.46%
|
O:
-1.87%
H:
0.01%
C:
-0.55%
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
1.78%
|
O:
0.08%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.03%
|
O:
-2.99%
H:
3.64%
C:
3.48%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
-0.16%
|
O:
-0.46%
H:
0.0%
C:
-0.75%
VIR
S
|
$30.14
0.77%
0.76%
860K
|
Health Technology
|
2.57%
|
O:
0.62%
H:
2.22%
C:
1.94%
TNXP
|
$1.24
5.09%
4.84%
2.2M
|
Health Technology
|
5.08%
|
O:
-1.69%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-5.4%
|
O:
-1.44%
H:
0.0%
C:
0.0%
GILD
|
$84.51
3.83%
3.69%
13M
|
Health Technology
|
0.6%
|
O:
-1.95%
H:
0.16%
C:
-1.18%
global
antiviral
growth
market
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2022
Published:
2023-02-02
(Crawled : 13:00)
- biospace.com/
XYF
|
News
|
$3.93
0.57%
0.0%
7.4K
|
Finance
|
-3.27%
|
O:
1.49%
H:
0.0%
C:
-4.69%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.03%
|
O:
-2.99%
H:
3.64%
C:
3.48%
for
financial
results
Global Antiviral Therapies Market Anticipated to Gather $66,016.5 Million and Grow at 3.1% CAGR in the 2020-2027 Forecast Period [208-Pages] | Details by Research Dive
Published:
2023-01-27
(Crawled : 13:20)
- prnewswire.com
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
-2.09%
|
O:
-0.5%
H:
0.0%
C:
0.0%
GSK
|
$34.83
-0.85%
0.03%
3.6M
|
Health Technology
|
0.14%
|
O:
0.06%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
0.19%
|
O:
-0.27%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
-0.77%
|
O:
-0.18%
H:
0.0%
C:
0.0%
research
global
antiviral
market
Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Adult Patients with Anemia-Associated, Non-Transfusion-Dependent (NTD) Beta Thalassemia
Published:
2023-01-27
(Crawled : 13:00)
- biospace.com/
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
0.19%
|
O:
-0.27%
H:
0.0%
C:
0.0%
reblozyl
for
chmp
positive
Bristol Myers Squibb Announces Positive CHMP Opinion for Once-Daily Sotyktu (deucravacitinib) as a Treatment for Adults With Moderate-to-Severe Plaque Psoriasis
Published:
2023-01-27
(Crawled : 13:00)
- biospace.com/
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
0.19%
|
O:
-0.27%
H:
0.0%
C:
0.0%
AMGN
|
$245.12
-0.57%
-0.58%
3.1M
|
Health Technology
|
-2.82%
|
O:
-0.57%
H:
0.0%
C:
0.0%
treatment
for
chmp
psoriasis
positive
Intravitreal Injectables Global Market Report 2022: Featuring Allergan, Bristol-Myers Squibb, Novartis, F.Hoffman-La Roche & More
Published:
2023-01-26
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$86.075
0
|
Health Technology
|
-3.77%
|
O:
-1.1%
H:
0.0%
C:
0.0%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.64%
|
O:
-1.25%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
0.89%
|
O:
0.7%
H:
0.0%
C:
0.0%
REGN
|
$782.76
4.2%
4.03%
1.4M
|
Health Technology
|
4.96%
|
O:
1.46%
H:
0.0%
C:
0.0%
global
report
roche
market
Bristol Myers Squibb Announces TRANSCEND CLL 004 Trial of Breyanzi® (lisocabtagene maraleucel) Met Primary Endpoint of Complete Response Rate in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Published:
2023-01-26
(Crawled : 13:20)
- biospace.com/
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
0.89%
|
O:
0.7%
H:
0.0%
C:
0.0%
breyanzi
leukemia
trial
response
transcend
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published:
2023-01-19
(Crawled : 17:00)
- prnewswire.com
TAK
|
$15.97
1.46%
0.0%
3.5M
|
Health Technology
|
-2.48%
|
O:
0.03%
H:
0.0%
C:
0.0%
NVO
|
$136.79
3.36%
1.17%
1.8M
|
Health Technology
|
-2.93%
|
O:
0.14%
H:
0.0%
C:
0.0%
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.62%
|
O:
0.0%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
-3.43%
|
O:
-1.45%
H:
0.0%
C:
0.0%
GSK
|
$34.83
-0.85%
0.03%
3.6M
|
Health Technology
|
0.45%
|
O:
0.23%
H:
0.0%
C:
0.0%
LLY
M
|
$339.08
2.53%
0.83%
5.7M
|
Health Technology
|
-6.86%
|
O:
-1.35%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.52%
|
O:
0.19%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
-3.75%
|
O:
-2.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-7.7%
|
O:
-0.92%
H:
0.0%
C:
0.0%
GILD
|
$84.51
3.83%
3.69%
13M
|
Health Technology
|
0.91%
|
O:
0.43%
H:
0.0%
C:
0.0%
AMGN
|
$245.12
-0.57%
-0.58%
3.1M
|
Health Technology
|
-5.76%
|
O:
-0.9%
H:
0.0%
C:
0.0%
global
report
growth
market
Dermatology Drugs Market to Experience Substantial Growth of USD 37.33 Million by 2029, Size, Share, Growth Rate, Market Demand, Opportunities and Competitive Landscape: Report by Data Bridge Market Research
Published:
2023-01-18
(Crawled : 19:00)
- prnewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-6.62%
|
O:
0.0%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
-3.43%
|
O:
-1.45%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.52%
|
O:
0.19%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-7.7%
|
O:
-0.92%
H:
0.0%
C:
0.0%
AMGN
|
$245.12
-0.57%
-0.58%
3.1M
|
Health Technology
|
-5.76%
|
O:
-0.9%
H:
0.0%
C:
0.0%
research
report
growth
market
Global Antiviral Therapeutics Market 2022 to 2027 - Rising Prevalence of Viral Diseases like HIV and Hepatitis Drives Growth
Published:
2023-01-16
(Crawled : 20:00)
- prnewswire.com
PFE
2 d
|
$44.06
-0.63%
-0.02%
24M
|
Health Technology
|
-7.2%
|
O:
-2.74%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
-4.36%
|
O:
0.51%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
2.12%
|
O:
1.94%
H:
0.52%
C:
-1.09%
ABT
|
News
|
$111.79
-0.41%
0.0%
3.8M
|
Health Technology
|
0.63%
|
O:
2.05%
H:
0.69%
C:
-0.1%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-6.8%
|
O:
1.1%
H:
0.22%
C:
0.02%
GILD
|
$84.51
3.83%
3.69%
13M
|
Health Technology
|
-1.11%
|
O:
0.7%
H:
0.37%
C:
-0.74%
hepatitis
global
antiviral
hiv
therapeutics
growth
market
Charles LaPree
Published:
2023-01-12
(Crawled : 21:00)
- savarapharma.com
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
-5.52%
|
O:
-0.83%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.81%
|
O:
-0.36%
H:
0.37%
C:
-0.11%
Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.
Published:
2023-01-11
(Crawled : 14:00)
- biospace.com/
JNJ
|
News
|
$164.61
-0.56%
-0.01%
6.8M
|
Health Technology
|
-5.51%
|
O:
0.01%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
2.75%
|
O:
0.32%
H:
0.66%
C:
0.6%
WBA
A
|
$37.09
-1.64%
-1.67%
5.9M
|
Retail Trade
|
3.67%
|
O:
2.27%
H:
0.24%
C:
-0.22%
GERN
|
$3.23
-3.29%
-3.41%
4.7M
|
Health Technology
|
13.99%
|
O:
11.95%
H:
0.0%
C:
0.0%
AMGN
|
$245.12
-0.57%
-0.58%
3.1M
|
Health Technology
|
-8.38%
|
O:
1.54%
H:
0.0%
C:
0.0%
for
commercial
CAR-T Cell Therapy Market Size to Reach USD 9.62 Million in 2030| Emergen Research
Published:
2023-01-09
(Crawled : 16:00)
- prnewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-5.57%
|
O:
1.97%
H:
0.0%
C:
0.0%
LLY
M
|
$339.08
2.53%
0.83%
5.7M
|
Health Technology
|
-7.54%
|
O:
1.12%
H:
0.27%
C:
-3.89%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.23%
|
O:
1.06%
H:
0.05%
C:
-2.89%
BNTX
|
$141.94
-1.7%
-1.73%
380K
|
Health Technology
|
-2.11%
|
O:
2.93%
H:
0.0%
C:
0.0%
research
car-t
therapy
market
Blueprint Medicines Appoints John Tsai, M.D. to its Board of Directors
Published:
2023-01-06
(Crawled : 14:20)
- prnewswire.com
NVS
|
$85.85
-0.29%
-0.29%
3.9M
|
Health Technology
|
-5.5%
|
O:
0.08%
H:
0.0%
C:
0.0%
GE
|
$81.96
-2.36%
0.09%
5.8M
|
Electronic Technology
|
19.51%
|
O:
3.1%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.93%
|
O:
0.7%
H:
0.0%
C:
0.0%
BPMC
|
$45.64
-6.97%
-7.49%
810K
|
Health Technology
|
1.94%
|
O:
-1.78%
H:
0.0%
C:
0.0%
AMGN
|
$245.12
-0.57%
-0.58%
3.1M
|
Health Technology
|
-5.41%
|
O:
2.43%
H:
0.0%
C:
0.0%
Hestia Insight Inc. Appoints Advisory Board Member to Assist in Company Growth
Published:
2023-01-05
(Crawled : 12:20)
- globenewswire.com
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.13%
|
O:
-0.79%
H:
0.0%
C:
0.0%
growth
Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
Published:
2023-01-04
(Crawled : 21:00)
- prnewswire.com
GSK
|
$34.83
-0.85%
0.03%
3.6M
|
Health Technology
|
-0.59%
|
O:
-2.81%
H:
0.0%
C:
0.0%
LLY
M
|
$339.08
2.53%
0.83%
5.7M
|
Health Technology
|
-8.46%
|
O:
-0.69%
H:
0.0%
C:
0.0%
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.13%
|
O:
-0.79%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$145.2
0.25%
0.0%
6.5M
|
Health Technology
|
-10.59%
|
O:
-0.39%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-6.74%
|
O:
-3.07%
H:
0.0%
C:
0.0%
global
active
report
teva
market
Bristol Myers Squibb to Present at J.P. Morgan’s 41st Annual Healthcare Conference
Published:
2023-01-03
(Crawled : 14:00)
- biospace.com/
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.45%
|
O:
-0.58%
H:
0.0%
C:
0.0%
conference
Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, New York
Published:
2023-01-03
(Crawled : 14:00)
- biospace.com/
BMY
A
|
$74.45
2.31%
-0.54%
10M
|
Health Technology
|
1.45%
|
O:
-0.58%
H:
0.0%
C:
0.0%
← Previous
1
2
3
4
5
6
7
8
9
…
22
23
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.